Trocar Site Hernia After Laparoscopic Cholecystectomy, Supra Versus Infraumbilical Incision for Umbilical Trocar Entry (HOT)
Primary Purpose
Incisional Hernia, Cholecystectomy, Laparoscopic
Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Infraumbilical Hasson trocar incision
Supraumbilical Hasson trocar incision
Sponsored by
About this trial
This is an interventional prevention trial for Incisional Hernia focused on measuring Trocar site hernia, Laparoscopy, Laparoscopic cholecystectomy, Minimally invasive surgery
Eligibility Criteria
Inclusion Criteria:
- Over 18 years old.
- Ability to understand the trial information.
- Patients with symptomatic gallstones or polyps scheduled for laparoscopic cholecystectomy.
- Elective surgery.
- One year potential follow-up.
Patients that experience one or more of the following Trocar Site Hernia risk factors:
- Over 60 years old.
- Obesity, defined as Body Mass Index (BMI) > 30 Kg/m2.
- Diabetes mellitus (DM).
- Bronchopathy: A diagnosed Chronic Obstructive Pulmonary Disease (COPD) or smokers of more than 25 cigarette packages/year.
- Accept to participate in the study and sign the informed consent.
Exclusion Criteria:
- Contraindication to conduct a laparoscopic cholecystectomy.
- Patients with previous open supramesocolic surgery.
- Patients with previous surgery that affects the umbilical region.
- Patients with umbilical hernia or history of umbilical hernia surgical correction.
- A greater than 30 cm xifo-umbilical distance.
- Extreme obesity (Body Mass Index > 50 kg/m2).
- Cancer patients or in immunosuppressive therapy.
- Connective tissue disease.
Sites / Locations
- La Mancha Centro General Hospital
- Tomelloso General Hospital
- Valdepeñas General Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Sham Comparator
Arm Label
Intervention group
Control group
Arm Description
Infraumbilical Hasson trocar incision.
Supraumbilical Hasson trocar incision.
Outcomes
Primary Outcome Measures
Trocar site hernia
Number of patients presenting a trocar site hernia, at the periumbilical incision, one year after laparoscopic cholecystectomy.
Secondary Outcome Measures
Umbilical wound complications different from Trocar Site Hernia
Infection, seroma or ecchymosis at the umbilical wound
Non-umbilical wounds complications
Hernia, infection, seroma, ecchymosis or evisceration at non-umbilical wounds.
Other complications
Other complications not related to the surgical wound
Surgical time
Measured in minutes from the first incision until the complete closure of the last surgical wound
Conversion
Conversion rate to open surgery (yes/no).
Hospital stay
Measured in hours from the surgery to the patient discharge.
Postoperative pain
Measured using the Visual Analogue Scale (VAS), with a punctuation between 0 (no pain) and 10 (the worst conceivable pain).
Perceived Quality of Life
Measured using the SF-36 questionnaire,
Aesthetic result
Measured using the Visual Analogue Scale, with a punctuation between 0 (not at all satisfied) and 10 (maximum satisfaction).
Full Information
NCT ID
NCT04254237
First Posted
February 1, 2020
Last Updated
September 3, 2023
Sponsor
Complejo Hospitalario La Mancha Centro
1. Study Identification
Unique Protocol Identification Number
NCT04254237
Brief Title
Trocar Site Hernia After Laparoscopic Cholecystectomy, Supra Versus Infraumbilical Incision for Umbilical Trocar Entry
Acronym
HOT
Official Title
Trocar Site Hernia After Laparoscopic Cholecystectomy: Randomized Clinical Trial Comparing Supra Versus Infraumbilical Incision for Umbilical Trocar Entry
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
February 6, 2020 (Actual)
Primary Completion Date
March 30, 2023 (Actual)
Study Completion Date
March 30, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Complejo Hospitalario La Mancha Centro
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Trocar site hernia is a specific complication of laparoscopic surgery. The increasingly frequent use of the laparoscopic approach has resulted in an increase in the number of hernias, mainly at the umbilical area. The appearance of a trocar site hernia can cause complications in the short and long term to the patient who may end up needing a reoperation.
In this study we want to compare the supraumbilical versus the infraumbilical location of the laparoscopy entry trocar, in terms of incisional hernia incidence.
Detailed Description
Trocar site hernias have been considered as an underestimated problem by some surgeons. It's incidence varies in the literature between studies, which may be related to an insufficient diagnosis due to poor clinical manifestation and / or the lack of long-term follow-up of patients in some studies.
There are many risk factors that have been related to the trocar site hernia development. On one side, the patient clinical factors as the age, presence of obesity, diabetes mellitus or the smoking habits. On the other side, some risk factors related to the surgical technique have been described, as the entry technique, the size and the locations of the trocars, the fascial closure, the duration of the surgery or the infection of the surgical wound.
Regarding the location of the trocars, it seems that the middle line has more risk of incisional hernia than the lateral areas in the abdomen. However, the trocar locations out of the middle line is not always possible, especially in certain surgeries as the laparoscopic cholecystectomy where it can be necessary an expansion of the incision for removing the specimen. In the concrete case of laparoscopic cholecystectomy, the belly is usually the most popular region for placing the first trocar. However, there is not much evidence about the influence of the most popular locations of the umbilical trocar incision (supra or infraumbilical) in the development of incisional hernias.
In the middle line, the infraumbilical region presents a great ability to adapt to pressure changes, as it physiologically occurs during the pregnancy. On the other side, while the primary hernias in the supraumbilical and umbilical region are common, these are not produced in the infraumbilical region. Besides, in anatomical studies of the linea alba, a higher thickness of the fibres in the infraumbilical region has been observed, along with a different spatial arrangement, predominating the transverse fibres in the infraumbilical region and the oblique ones in the supraumbilical region. Therefore, we hypothesize whether the infraumbilical location of the trocar in the midline, theoretically a more protected region, can reduce the incidence of trocar site hernia in our patients.
The aim of this study is to compare the incidence of the Hasson trocar site hernia between the supra and infraumbilical locations a year after surgery, in high risk patients for trocar site hernia subjected to elective laparoscopic cholecystectomy.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Incisional Hernia, Cholecystectomy, Laparoscopic
Keywords
Trocar site hernia, Laparoscopy, Laparoscopic cholecystectomy, Minimally invasive surgery
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
130 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention group
Arm Type
Active Comparator
Arm Description
Infraumbilical Hasson trocar incision.
Arm Title
Control group
Arm Type
Sham Comparator
Arm Description
Supraumbilical Hasson trocar incision.
Intervention Type
Procedure
Intervention Name(s)
Infraumbilical Hasson trocar incision
Intervention Description
Infraumbilical Hasson trocar incision
Intervention Type
Procedure
Intervention Name(s)
Supraumbilical Hasson trocar incision
Intervention Description
Supraumbilical Hasson trocar incision
Primary Outcome Measure Information:
Title
Trocar site hernia
Description
Number of patients presenting a trocar site hernia, at the periumbilical incision, one year after laparoscopic cholecystectomy.
Time Frame
One year
Secondary Outcome Measure Information:
Title
Umbilical wound complications different from Trocar Site Hernia
Description
Infection, seroma or ecchymosis at the umbilical wound
Time Frame
24 hours, 7 days, 30 days, 6 months and 1 year.
Title
Non-umbilical wounds complications
Description
Hernia, infection, seroma, ecchymosis or evisceration at non-umbilical wounds.
Time Frame
24 hours, 7 days, 30 days, 6 months and 1 year.
Title
Other complications
Description
Other complications not related to the surgical wound
Time Frame
24 hours, 7 days, 30 days, 6 months and 1 year.
Title
Surgical time
Description
Measured in minutes from the first incision until the complete closure of the last surgical wound
Time Frame
Day 0
Title
Conversion
Description
Conversion rate to open surgery (yes/no).
Time Frame
Day 0
Title
Hospital stay
Description
Measured in hours from the surgery to the patient discharge.
Time Frame
Day 0
Title
Postoperative pain
Description
Measured using the Visual Analogue Scale (VAS), with a punctuation between 0 (no pain) and 10 (the worst conceivable pain).
Time Frame
24 hours and 7 days after surgery.
Title
Perceived Quality of Life
Description
Measured using the SF-36 questionnaire,
Time Frame
baseline, one month and a year after surgery.
Title
Aesthetic result
Description
Measured using the Visual Analogue Scale, with a punctuation between 0 (not at all satisfied) and 10 (maximum satisfaction).
Time Frame
Six months and a year of the surgery.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Over 18 years old.
Ability to understand the trial information.
Patients with symptomatic gallstones or polyps scheduled for laparoscopic cholecystectomy.
Elective surgery.
One year potential follow-up.
Patients that experience one or more of the following Trocar Site Hernia risk factors:
Over 60 years old.
Obesity, defined as Body Mass Index (BMI) > 30 Kg/m2.
Diabetes mellitus (DM).
Bronchopathy: A diagnosed Chronic Obstructive Pulmonary Disease (COPD) or smokers of more than 25 cigarette packages/year.
Accept to participate in the study and sign the informed consent.
Exclusion Criteria:
Contraindication to conduct a laparoscopic cholecystectomy.
Patients with previous open supramesocolic surgery.
Patients with previous surgery that affects the umbilical region.
Patients with umbilical hernia or history of umbilical hernia surgical correction.
A greater than 30 cm xifo-umbilical distance.
Extreme obesity (Body Mass Index > 50 kg/m2).
Cancer patients or in immunosuppressive therapy.
Connective tissue disease.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Antonio Morandeira-Rivas, MD PhD
Organizational Affiliation
La Mancha Centro General Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Carlos Moreno Sanz, MD PhD FACS
Organizational Affiliation
La Mancha Centro General Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
La Mancha Centro General Hospital
City
Alcázar de San Juan
State/Province
Ciudad Real
ZIP/Postal Code
13600
Country
Spain
Facility Name
Tomelloso General Hospital
City
Tomelloso
State/Province
Ciudad Real
ZIP/Postal Code
13700
Country
Spain
Facility Name
Valdepeñas General Hospital
City
Valdepeñas
State/Province
Ciudad Real
ZIP/Postal Code
13300
Country
Spain
12. IPD Sharing Statement
Learn more about this trial
Trocar Site Hernia After Laparoscopic Cholecystectomy, Supra Versus Infraumbilical Incision for Umbilical Trocar Entry
We'll reach out to this number within 24 hrs